Editor’s note: This story includes discussion of suicide. If you or someone you know needs help, the national suicide and…
Articles by Michela Luciano, PhD
An experimental brain-computer interface that helped a man with amyotrophic lateral sclerosis (ALS) communicate again has earned a neuroscientist at…
The anticipated availability and subsequent approval in Canada of the first gene-targeted therapy for certain people with amyotrophic lateral…
A self-balancing, hands-free robotic exoskeleton designed for people with severe gait impairment was safe and well tolerated …
A University of Melbourne spinout company is developing a less invasive brain-computer interface that could one day allow people with…
Former NFL running back Chris Johnson, whose historic 2,000 rushing yards in a season earned him the nickname CJ2K, has…
Masitinib treatment was linked to a nearly doubled five-year survival rate among people with amyotrophic lateral sclerosis (ALS),…
A team at Stanford University has received a $13 million grant to uncover previously unknown genetic causes of amyotrophic…
AC Immune’s experimental imaging agent ACI-19626 continues to show a good safety profile and has shown promise for detecting…
COYA 302, Coya Therapeutics’ investigational therapy for amyotrophic lateral sclerosis (ALS) — shown in an early clinical trial…